Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling
Ding‐Sheng Jiang, Wei Xiang, Xiaofei Zhang, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
Yow Keat Tham, Bianca C. Bernardo, Jenny Y. Y. Ooi, et al.
Archives of Toxicology (2015) Vol. 89, Iss. 9, pp. 1401-1438
Closed Access | Times Cited: 611
The interaction between ferroptosis and inflammatory signaling pathways
Yue Chen, Zemin Fang, Xin Yi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 215
Calcium Signaling and Transcriptional Regulation in Cardiomyocytes
Matthias Dewenter, Albert von der Lieth, Hugo A. Katus, et al.
Circulation Research (2017) Vol. 121, Iss. 8, pp. 1000-1020
Open Access | Times Cited: 198
Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease
Guang‐Nian Zhao, Zhi‐Gang She, Hongliang Li
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1852, Iss. 2, pp. 365-378
Open Access | Times Cited: 197
Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets
Bonan Chen, Peiyao Yu, Wai Nok Chan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 93
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
Yan‐Xiao Ji, Peng Zhang, Xiao‐Jing Zhang, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 155
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Yao Yu, Jingjing Cai, Zhi‐Gang She, et al.
Advanced Science (2018) Vol. 6, Iss. 4
Open Access | Times Cited: 153
Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKα/Smad3 signaling
Xin Zhang, Zhen‐Guo Ma, Yu‐Pei Yuan, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 124
Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways
Zhen‐Guo Ma, Yu‐Pei Yuan, Xin Zhang, et al.
EBioMedicine (2017) Vol. 18, pp. 179-187
Open Access | Times Cited: 122
Protection against cardiac hypertrophy by geniposide involves the GLP‐1 receptor / AMPKα signalling pathway
Zhen‐Guo Ma, Jia Dai, Wenbin Zhang, et al.
British Journal of Pharmacology (2016) Vol. 173, Iss. 9, pp. 1502-1516
Open Access | Times Cited: 102
Weighted Gene Co-Expression Network Analysis Identifies Critical Genes in the Development of Heart Failure After Acute Myocardial Infarction
Xiaowei Niu, Jingjing Zhang, Lanlan Zhang, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 93
Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases
Meng Xu, Peter P. Liu, Hongliang Li
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 893-948
Open Access | Times Cited: 86
Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
Jingjing Cai, Meng Xu, Xiao‐Jing Zhang, et al.
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 14, Iss. 1, pp. 153-184
Open Access | Times Cited: 84
The multiple roles of interferon regulatory factor family in health and disease
Luyao Wang, Yanghui Zhu, Nan Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Interferon Regulatory Factor 1 Is Required for Cardiac Remodeling in Response to Pressure Overload
Ding‐Sheng Jiang, Liangpeng Li, Ling Huang, et al.
Hypertension (2014) Vol. 64, Iss. 1, pp. 77-86
Open Access | Times Cited: 87
EZH2 inhibits autophagic cell death of aortic vascular smooth muscle cells to affect aortic dissection
Rui Li, Xin Yi, Wei Xiang, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 79
Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy
Man Xu, Chun‐Xia Wan, Sihui Huang, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 6
Open Access | Times Cited: 68
Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction
Mingwei Bao, Zhongxiang Cai, Xiao‐Jing Zhang, et al.
Basic Research in Cardiology (2015) Vol. 110, Iss. 3
Closed Access | Times Cited: 66
Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
Ke‐Qiong Deng, Aibing Wang, Yan‐Xiao Ji, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 66
The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation
Qian Wang, Ying Yu, Pengpai Zhang, et al.
Basic Research in Cardiology (2017) Vol. 112, Iss. 4
Closed Access | Times Cited: 65
Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway
Zhen‐Guo Ma, Jia Dai, Wenying Wei, et al.
International Journal of Biological Sciences (2016) Vol. 12, Iss. 7, pp. 861-871
Open Access | Times Cited: 63
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
Małgorzata Szeląg, Anna Piaszyk-Borychowska, Martyna Plens-Gałąska, et al.
Oncotarget (2016) Vol. 7, Iss. 30, pp. 48788-48812
Open Access | Times Cited: 61
Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics
Jamie R. Bhagwan, Diogo Mosqueira, Karolina Chairez‐Cantu, et al.
Journal of Molecular and Cellular Cardiology (2020) Vol. 145, pp. 43-53
Open Access | Times Cited: 56
MiR-125b inhibits cardiomyocyte apoptosis by targeting BAK1 in heart failure
Bei Zhang, Shanyong Mao, Xingde Liu, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 55
Interferons and interferon-related pathways in heart disease
Duc Tin Tran, Sri Nagarjun Batchu, Andrew Advani
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top